⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

October 27, 2022Journal of Asthma

Use of FeNO to predict anti-IL-5 and IL-5R biologics efficacy in a real-world cohort of adults with severe eosinophilic asthma

Charlotte Ménigoz S. Dirou Arnaud Chambellan Dorian Hassoun Antoine Moui A. Magnan F.–X. Blanc

View at Publisher

Ask AI

Bookmark

Share

Abstract

In this real-world cohort, adults with SEA who had a baseline FeNO ≥50 ppb experienced a greater decrease in exacerbations after 12 months of anti-IL-5 or IL-5R biologics than those with a FeNO <50 ppb.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Ménigoz et al. (2022) studied this question.

synapsesocial.com/papers/69da6f4e387cf70698686af3 https://doi.org/10.1080/02770903.2022.2136526

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1International ERS/ATS guidelines on definition, evaluation and treatment of severe asthmaNarrative Review · 2013 · 3,925 citations
2Healthcare resource use and costs of severe, uncontrolled eosinophilic asthma in the UK general populationCohort Study · 2017 · 160 citations
3IL‐13 induced increases in nitrite levels are primarily driven by increases in inducible nitric oxide synthase as compared with effects on arginases in human primary bronchial epithelial cellsOriginal Research · 2008 · 214 citations
4The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthmaObservational Study · 2005 · 321 citations
5Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma.Cross-Sectional Study · 1998 · 689 citations

More related papers

External validation of blood eosinophils, FE <sub>NO</sub> and serum periostin as surrogates for sputum eosinophils in asthma2014
Prospective predictors of exacerbation status in severe asthma over a 3‐year follow‐up2018
Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma2014

More from Journal of Asthma

Association Between Serum Magnesium Status and Bronchial Asthma Severity: A Gender-Matched Retrospective Cohort StudyWed,
Changing Patterns of Diagnostic Testing in Children With Asthma: Evidence of Redistribution, Overuse, and Recovery After the COVID-19 PandemicMon,